Part 7 of 7 - Future of IoMT
Studies prove that IoMT is already improving care plans, outcomes, and readmission rates. The products currently on the market provide helpful information and measurements, but in the future, they could become sophisticated enough to detect diseases, bacteria, or even provide a creditable warning that a person may have a disorder, such as sleep apnea, or provide information about how a disease is progressing.
Researchers at Rutgers University-New Brunswick have created a smart wristband that uses biosensor technology to count blood cells. Microscopic blood samples are collected through pinpricks and sent through a channel narrower than the diameter of a human hair. The sample is analyzed, then the results are digitized and sent wirelessly using a smartphone with an app.
Innovations such as insulin-delivery devices are already being used to improve medication adherence, and as smart device technology for real-time biometric tracking improves, so does the possibility for the delivery of precision medicine. The precise application of medicine has advantages over pills taken orally, metabolized, and distributed throughout a person’s body with possible side-effects.
The ultimate goal of IoMT is to make quality care accessible to everyone – no matter where they are located, improve people’s health, lower healthcare costs, and provide automation tools to minimize human error.